U.S. stock night market opening fluctuations: BHP rose 4.03% in night trading; MDxHealth SA fell 3.78% in night trading
I'm LongbridgeAI, I can summarize articles.BHP night trading rose 4.03%; MDxHealth SA night trading fell 3.78%; Amylyx Pharmaceuticals night trading rose 12.04%; Duos Tech night trading rose 9.44%; Fundrise Innovation Fund LLC night trading rose 6.39%
U.S. Stock Night Market Opening Movements
BHP rose 4.03% in the night market. Based on recent key news:
-
On August 18, BHP Group announced its financial report, with annual underlying profit rising to $13.2 billion, a year-on-year increase of 30%, exceeding analyst expectations. Revenue from the copper business surpassed that of iron ore for the first time, driving the stock price up. Source: Zhitong Finance
-
On August 18, BHP announced a final dividend of $0.99, with a payout ratio of 72%. The high payout ratio boosted investor confidence, further increasing the stock price. Source: Zhitong Finance
-
On August 18, BHP CEO Brendan Craig stated that copper is the core engine driving the company's growth, and global copper demand is expected to increase significantly in the future. The market is optimistic about the company's copper business prospects, leading to a rise in stock price. Source: Zhitong Finance. Commodity prices are rising, and copper demand is strong.
MDxHealth SA fell 3.78% in the night market. Based on recent key news:
-
On August 15, MDxHealth raised $20 million through registered direct financing, eliminating $10.4 million in contingent liabilities, enhancing its balance sheet and cash position. This move improved the company's financial health; however, the stock price still experienced volatility.
-
On August 15, MDxHealth reaffirmed its 2026 sales guidance of $110 million to $115 million, higher than the market expectation of $98.814 million, with a projected year-on-year growth of 20-26%. Despite the optimistic sales outlook, the market remains skeptical about its execution capabilities, leading to stock price fluctuations.
-
On August 15, MDxHealth expects its organizational business to recover after the integration and restructuring of the sales team following the ExoDx acquisition, with the number of organizational tests increasing by over 1,400 compared to the previous month. The market lacks confidence in its business recovery, affecting stock performance. Industry consolidation is accelerating, and capital flow is significant.
Top Gainers in the U.S. Stock Night Market
Amylyx Pharmaceuticals rose 12.04% in the night market. Based on recent key news:
-
On August 17, Amylyx Pharmaceuticals announced it would release top-line results from a Phase 3 trial evaluating a treatment for a type of hypoglycemia. This news drove the stock price up 15% to $24.58. The FDA has granted the drug breakthrough therapy and orphan drug designation.
-
On August 17, Mizuho analyst Graig Suvannavejh raised the company's target price from $24 to $30 and maintained an outperform rating. The analyst believes that if the Phase 3 data proves positive, there is further upside potential for the stock price.
-
On August 17, Amylyx Pharmaceuticals plans to hold a management conference call on August 18 to discuss the Phase 3 trial results. The market expects the drug to significantly reduce hypoglycemic events in patients. The pharmaceutical industry has performed strongly recently, with noticeable capital inflows Duos Tech rose 9.44% in after-hours trading. Based on recent key news:
-
On August 17, Duos Technologies released its second-quarter financial report, with a year-on-year revenue growth of 30% and a gross margin increase of 94%. The company also secured over $100 million in growth capital and reaffirmed its deployment target of 25 MW by 2026 and revenue exceeding $50 million. These positive financial performances drove the stock price up. Source: SEC announcement
-
On August 17, Duos Technologies signed a five-year custody agreement worth over $500 million with Axe Compute, involving 55 MW of AI data center capacity. This significant partnership agreement enhanced market confidence in the company's future growth, further driving the stock price up. Source: Reuters
-
On August 17, Duos Technologies appointed Dipan D. Patel as Chief Operating Officer and disclosed his holding of 200,000 shares of common stock. This executive change was viewed by the market as a positive adjustment in the company's management, boosting investor confidence. Source: EDGAR announcement. The demand for AI and data centers is growing, and the industry outlook is optimistic.
Fundrise Innovation Fund LLC rose 6.39% in after-hours trading. Based on recent key news:
-
On August 15, AST SpaceMobile announced that its satellite service will launch early next year, addressing mobile signal dead zones. This news boosted market confidence in related technology companies, driving up the stock price of Fundrise Innovation Fund LLC.
-
On August 14, overall optimism in technology stocks increased, with investors buying related stocks, further pushing up the stock price of Fundrise Innovation Fund LLC.
-
On August 13, analysts expressed optimism about the future prospects of the technology industry, expecting related companies to benefit from the application of new technologies and the growth of market demand, which enhanced investor confidence and led to a rise in stock prices. The technology sector has performed strongly recently, and investor sentiment is optimistic
